Tissue engineering of vascular conduits

British Journal of Surgery

Volumn 93, Issue 6, 2006, Pages 652-661

  Yow, K H ^a,b,c   Ingram, J ^a   Korossis, S A ^a   Ingham, E ^a   Homer Vanniasinkam, S ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN; COLLAGEN; DERMATAN; EDETIC ACID; ELASTIN; FIBROBLAST GROWTH FACTOR; GLYCOSAMINOGLYCAN; HEPARAN; HEPARIN; POLYGLYCOLIC ACID; POLYLACTIC ACID; POLYURETHAN; TRYPSIN; VASCULOTROPIN;

CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CYTOLOGY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GRAFT FAILURE; HEMODYNAMICS; HUMAN; IN VIVO STUDY; NONHUMAN; PHENOTYPE; POLITEF IMPLANT; PRIORITY JOURNAL; RETROVIRUS; REVIEW; STEM CELL; TISSUE ENGINEERING; VASCULAR SMOOTH MUSCLE;

BIOARTIFICIAL ORGANS; BIOMECHANICS; BLOOD VESSEL PROSTHESIS; CULTURE TECHNIQUES; HUMANS; TISSUE ENGINEERING;

EID: 33745065170     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.5343     Document Type: Review

References (88)

1. Langer R, Vacanti JP. Tissue engineering. Science 1993; 260: 920-926.
2. Wilt TJ, Bloomfield HE, MacDonald R, Nelson D, Rutks I, Ho M et al. Effectiveness of statin therapy in adults with coronary heart disease. Arch Intern Med 2004; 164: 1427-1436.
3. British Heart Foundation Health Promotion Research Group. Coronary Heart Disease Statistics: Factsheet. British Heart Foundation: London, 2004.
4. Babapulle MN, Joseph L, Belisle P, Brophy JM, Eisenberg MJ. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet 2004; 364: 583-591.
5. Ansell D, Feest T, Byrne C, Ahmad A. UK Renal Registry: The Sixth Annual Report. The Renal Association: Bristol, 2003.
6. Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991; 20: 384-392.
7. Piccone V. Alternative techniques in coronary artery reconstruction. In Modern Vascular Grafts, Sawyer PN (ed.). McGraw-Hill: New York, 1987; 253-260.
8. Clowes AW, Geary R. Vascular biology - the new frontier. Kinmonth Memorial Lecture. Vascular Surgical Society of Great Britain and Northern Ireland. London, November 1992. Cardiovasc Surg 1994; 2: 301-307.
9. Kim BS, Mooney DJ. Development of biocompatible synthetic extracellular matrices for tissue engineering. Trends Biotechnol 1998; 16: 224-230.
10. Tiwari A, Salacinski H, Seifalian AM, Hamilton G. New prostheses for use in bypass grafts with special emphasis on polyurethanes. Cardiovasc Surg 2002; 10: 191-197.
11. Niklason LE, Abbott W, Gao J, Klagges B, Hirschi KK, Ulubayram K et al. Morphologic and mechanical characteristics of engineered bovine arteries. J Vasc Surg 2001; 33: 628-638.
12. Tai NR, Salacinski HJ, Edwards A, Hamilton G, Seifalian AM. Compliance properties of conduits used in vascular reconstruction. Br J Surg 2000; 87: 1516-1524.
13. Higgins SP, Solan AK, Niklason LE. Effects of polyglycolic acid on porcine smooth muscle cell growth and differentiation. J Biomed Mater Res Part A 2003; 67: 295-302.
14. Conklin BS, Richter ER, Kreutziger KL, Zhong DS, Chen C. Development and evaluation of a novel decellularized vascular xenograft. Med Eng Phys 2002; 24: 173-183.
15. Schaner PJ, Martin ND, Tulenko TN, Shapiro LM, Tarola NA, Leichter RF et al. Decellularized vein as a potential scaffold for vascular tissue engineering. J Vasc Surg 2004; 40: 146-153.
16. Noishiki Y, Yamane Y, Miyata T. Long-term evaluation of a growable graft. ASAIO Trans 1989; 35: 267-270.
17. Teebken OE, Bader A, Steinhoff G, Haverich A. Tissue engineering of vascular grafts: human cell seeding of decellularised porcine matrix. Eur J Vasc Endovasc Surg 2000; 19: 381-386.
18. Kaushal S, Amiel GE, Guleserian KJ, Shapira OM, Perry T, Sutherland FW et al. Eunctional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 2001; 7: 1035-1040.
19. Lantz GC, Badylak SF, Hues MC, Coffey AC, Geddes LA, Kokini K et al. Small intestinal submucosa as a vascular graft: a review. J Invest Surg 1993; 6: 297-310.
20. Clarke DR, Lust RM, Sun YS, Black KS, Ollerenshaw JD. Transformation of nonvascular acellular tissue matrices into durable vascular conduits. Ann Thorac Surg 2001; 71 (Suppl): S433-S436.
21. Lantz GC, Badylak SF, Coffey AC, Geddes LA, Blevins WE. Small intestinal submucosa as a small-diameter arterial graft in the dog. J Invest Surg 1990; 3: 217-227.
22. Lantz GC, Badylak SF, Coffey AC, Geddes LA, Sandusky GE. Small intestinal submucosa as a superior vena cava graft in the dog. J Surg Res 1992; 53: 175-181.
23. Badylak SF, Lantz GC, Coffey A, Geddes LA. Small intestinal submucosa as a large diameter vascular graft in the dog. J Surg Res 1989; 47: 74-80.
24. Huynh T, Abraham G, Murray J, Brockbank K, Hagen PO, Sullivan S. Remodeling of an acellular collagen graft into a physiologically responsive neovessel. Nat Biotechnol 1999; 17: 1083-1086.
25. Weinberg CB, Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science 1986; 231: 397-400.
26. L'Heureux N, Paquet S, Labbe R, Germain L, Auger FA. A completely biological tissue-engineered human blood vessel. FASEB J 1998; 12: 47-56.
27. Booth C, Korossis SA, Wilcox HE, Watterson KG, Kearney JN, Fisher J et al. Tissue engineering of cardiac valve prostheses I: development and histological characterization of an acellular porcine scaffold. J Heart Valve Dis 2002; 11: 457-462.
28. Koyama H, Raines EW, Bornfeldt KE, Roberts JM, Ross R. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell 1996; 87: 1069-1078.
29. Li DY, Brooke B, Davis EC, Mecham RP, Sorensen LK, Boak BB et al. Elastin is an essential determinant of arterial morphogenesis. Nature 1998; 393: 276-280.
30. Wight TN. Cell biology of arterial proteoglycans. Arteriosclerosis 1989; 9: 1-20.
31. Bingley JA, Hayward IP, Campbell JH, Campbell GR. Arterial heparan sulfate proteoglycans inhibit vascular smooth muscle cell proliferation and phenotype change in vitro and neointimal formation in vivo. J Vasc Surg 1998; 28: 308-318.
32. Voytik-Harbin SL, Brightman AO, Kraine MR, Waisner B, Badylak SF. Identification of extractable growth factors from small intestinal submucosa. J Cell Biochem 1997; 67: 478-491.
33. Gillis C, Bengtsson L, Wilman B, Haegerstrand A. Secretion of prostacyclin, tissue plasminogen activator and its inhibitor by cultured adult human endothelial cells grown on different matrices. Eur J Vasc Endovasc Surg 1996; 11: 127-133.
34. Niklason LE, Gao J, Abbott WM, Hirschi KK, Houser S, Marini R et al. Functional arteries grown in vitro. Science 1999; 284: 489-493.
35. Jernigan TW, Croce MA, Cagiannos C, Shell DH, Handorf CR, Fabian TC. Small intestinal submucosa for vascular reconstruction in the presence of gastrointestinal contamination. Ann Surg 2004; 239: 733-738, discussion 738-740.
36. Rosenman JE, Kempczinski RF, Berlatzky Y, Pearce WH, Ramalanjaona GR, Bjornson HS. Bacterial adherence to endothelial-seeded polytetrafluoroethylene grafts. Surgery 1985; 98: 816-823.
37. Kallenbach K, Leyh RG, Lefik E, Walles T, Wilhelmi M, Cebotari S et al. Guided tissue regeneration: porcine matrix does not transmit PERV. Biomaterials 2004; 25: 3613-3620.
38. Martin U, Winkler ME, Id M, Radeke H, Arseniev L, Takeuchi Y et al. Productive infection of primary human endothelial cells by pig endogenous retrovirus (PERV). Xenotransplantation 2000; 7: 138-142.
39. Paradis K, Langford G, Long Z, Heneine W, Sandstrom P, Switzer WM et al. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN III Study Group. Science 1999; 285: 1236-1241.
40. Walles T, Lichtenberg A, Puschmann C, Leyh R, Wilhelmi M, Kallenbach K et al. In vivo model for cross-species porcine endogenous retrovirus transmission using tissue engineered pulmonary arteries. Eur J Cardiothorac Surg 2003; 24: 358-363.
41. Thyberg J. Differentiated properties and proliferation of arterial smooth muscle cells in culture. Int Rev Cytol 1996; 169: 183-265.
42. Ott MJ, Ballermann BJ. Shear stress-conditioned, endothelial cell-seeded vascular grafts: improved cell adherence in response to in vitro shear stress. Surgery 1995; 117: 334-339.
43. Baguneid M, Murray D, Salacinski HJ, Fuller B, Hamilton G, Walker M et al. Shear-stress preconditioning and tissue-engineering-based paradigms for generating arterial substitutes. Biotechnol Appl Biochem 2004; 39: 151-157.
44. Miyata T, Conte MS, Trudell LA, Mason D, Whittemore AD, Birinyi LK. Delayed exposure to pulsatile shear stress improves retention of human saphenous vein endothelial cells on seeded ePTFE grafts. J Surg Res 1991; 50: 485-493.
45. Kanda K, Matsuda T, Oka T. Mechanical stress induced cellular orientation and phenotypic modulation of 3-D cultured smooth muscle cells. ASAIO J 1993; 39: M686-M690.
46. Seliktar D, Black RA, Vito RP, Nerem RM. Dynamic mechanical conditioning of collagen-gel blood vessel constructs induces remodeling in vitro. Ann Biomed Eng 2000; 28: 351-362.
47. Sodian R, Lemke T, Fritsche C, Hoerstrup SP, Fu P, Potapov EV et al. Tissue-engineering bioreactors: a new combined cell-seeding and perfusion system for vascular tissue engineering. Tissue Eng 2002; 8: 863-870.
48. Williams C, Wick TM. Perfusion bioreactor for small diameter tissue-engineered arteries. Tissue Eng 2004; 10: 930-941.
49. Roeder R, Wolfe J, Lianakis N, Hinson T, Geddes LA, Obermiller J. Compliance, elastic modulus, and burst pressure of small-intestine submucosa (SIS), small-diameter vascular grafts. J Biomed Mater Res 1999; 47: 65-70.
50. Campbell JH, Efendy JL, Campbell GR. Novel vascular graft grown within recipient's own peritoneal cavity. Circ Res 1999; 85: 1173-1178.
51. Barakat AI, Davies PF. Mechanisms of shear stress transmission and transduction in endothelial cells. Chest 1998; 114(Suppl): 58S-63S.
52. Radomski MW, Palmer RM, Moncada S. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol 1987; 92: 639-646.
53. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995; 96: 60-68.
54. Meinhart JG, Deutsch M, Fischlein T, Howanietz N, Froschl A, Zilla P. Clinical autologous in vitro endothelialization of 153 infrainguinal ePTFE grafts. Ann Thorac Surg 2001; 71(Suppl): S327-S331.
55. Veith FJ, Gupta SK, Ascer E, White-Flores S, Samson RH, Scher LA et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 1986; 3: 104-114.
56. Guyton AC, Hall JE. Haemostasis and blood coagulation. In Textbook of Medical Physiology, vol. 1 (10th edn). W.B. Saunders: Philadelphia, 2000; 419-429.
57. Quist WC, LoGerfo FW. Prevention of smooth muscle cell phenotypic modulation in vein grafts: a histomorphometric study. J Vasc Surg 1992; 16: 225-231.
58. Nugent HM, Rogers C, Edelman ER. Endothelial implants inhibit intimal hyperplasia after porcine angioplasty. Circ Res 1999; 84: 384-391.
59. Kockx MM, Gambier BA, Bortier HE, De Meyer GR, Van Cauwelaert PA. The modulation of smooth muscle cell phenotype is an early event in human aorto-coronary saphenous vein grafts. Virchows Arch A Pathol Anat Histopathol 1992; 420: 155-162.
60. Zilla P, Deutsch M, Meinhart J, Puschmann R, Eberl T, Minar E et al. Clinical In vitro endothelialization of femoropopliteal bypass grafts: an actuarial follow-up over three years. J Vasc Surg 1994; 19: 540-548.
61. Tiwari A, Salacinski HJ, Hamilton G, Seifalian AM. Tissue engineering of vascular bypass grafts: role of endothelial cell extraction. Eur J Vasc Endovasc Surg 2001; 21: 193-201.
62. Anders E, Alles JU, Delvos U, Potzsch B, Preissner KT, Muller-Berghaus G. Microvascular endothelial cells from human omental tissue: modified method for long-term cultivation and new aspects of characterization. Microvasc Res 1987; 34: 239-249.
63. Pronk A, Leguit P, Hoynck van Papendrecht AA, Hagelen E, van Vroonhoven TJ, Verbrugh HA. A cobblestone cell isolated from the human omentum: the mesothelial cell: isolation, identification, and growth characteristics. In Vitro Cell Dev Biol 1993; 29A: 127-134.
64. Sharp WV, Schmidt SP, Meerbaum SO, Pippert TR. Derivation of human microvascular endothelial cells for prosthetic vascular graft seeding. Ann Vasc Surg 1989; 3: 104-107.
65. Williams SK. Human clinical trials of microvascular endothelial cell sodding. In Tissue Engineering of Vascular Prosthetic Grafts, Zilla P, Greisler HP (eds). R.G. Landes: Austin, 1999; 143-147.
66. Sank A, Wei D, Reid J, Ertl D, Nimni M, Weaver F et al. Human endothelial cells are defective in diabetic vascular disease. J Surg Res 1994; 57: 647-653.
67. Rosenman JE, Kempczinski RF, Pearce WH, Silberstein EB. Kinetics of endothelial cell seeding. J Vasc Surg 1985; 2: 778-784.
68. Kent KC, Oshima A, Whittemore AD. Optimal seeding conditions for human endothelial cells. Ann Vasc Surg 1992; 6: 258-264.
69. Greisler HP, Cziperle DJ, Kim DU, Garfield JD, Petsikas D, Murchan PM et al. Enhanced endothelialization of expanded polytetrafluoroethylene grafts by fibroblast growth factor type 1 pretreatment. Surgery 1992; 112: 244-254, discussion 254-255.
70. Salacinski HJ, Tiwari A, Hamilton G, Seifalian AM. Cellular engineering of vascular bypass grafts: role of chemical coatings for enhancing endothelial cell attachment. Med Biol Eng Comput 2001; 39: 609-618.
71. Mann BK, Tsai AT, Scott-Burden T, West JL. Modification of surfaces with cell adhesion peptides alters extracellular matrix deposition. Biomaterials 1999; 20: 2281-2286.
72. Mann BK, West JL. Cell adhesion peptides alter smooth muscle cell adhesion, proliferation, migration, and matrix protein synthesis on modified surfaces and in polymer scaffolds. J Biomed Mater Res 2002; 60: 86-93.
73. Lemson MS, Tordoir JH, Daemen MJ, Kitslaar PJ. Intimal hyperplasia in vascular grafts. Eur J Vasc Endovasc Surg 2000; 19: 336-350.
74. Davies AH, Magee TR, Baird RN, Sheffield E, Horrocks M. Vein compliance: a preoperative indicator of vein morphology and of veins at risk of vascular graft stenosis. Br J Surg 1992; 79: 1019-1021.
75. Okuhn SP, Connelly DP, Calakos N, Ferrell L, Pan MX, Goldstone J. Does compliance mismatch alone cause neointimal hyperplasia? J Vasc Surg 1989; 9: 35-45.
76. Bassiouny HS, White S, Glagov S, Choi E, Giddens DP, Zarins CK. Anastomotic intimai hyperplasia: mechanical injury or flow induced. J Vasc Surg 1992; 15: 708-716, discussion 716-717.
77. Trubel W, Schima H, Moritz A, Raderer F, Windisch A, Ullrich R et al. Compliance mismatch and formation of distal anastomotic intimal hyperplasia in externally stiffened and lumen-adapted venous grafts. Eur J Vasc Endovasc Surg 1995; 10: 415-423.
78. Ballyk PD, Walsh C, Butany J, Ojha M. Compliance mismatch may promote graft-artery intimal hyperplasia by altering suture-line stresses. J Biomech 1998; 31: 229-237.
79. Canver CC. Conduit options in coronary artery bypass surgery. Chest 1995; 108: 1150-1155.
80. Pearson PJ, Evora PR, Schaff HV. Bioassay of EDRF from internal mammary arteries: implications for early and late bypass graft patency. Ann Thorac Surg 1992; 54: 1078-1084.
81. Teebken OE, Haverich A. Tissue engineering of small diameter vascular grafts. Eur J Vasc Endovasc Surg 2002; 23: 475-485.
82. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998; 92: 362-367.
83. Patterson C. The Ponzo effect: endothelial progenitor cells appear on the horizon. Circulation 2003; 107: 2995-2997.
84. Tepper OM, Capla JM, Galiano RD, Ceradini DJ, Callaghan MJ, Kleinman ME et al. Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Blood 2005; 105: 1068-1077.
85. Heeschen C, Aicher A, Lehmann R, Fichtischerer S, Vasa M, Urbich C et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 2003; 102: 1340-1346.
86. Walter DH, Rittig K, Bahlmann FH, Kirchmair R, Silver M, Murayama T et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002; 105: 3017-3024.
87. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809.
88. Abbott WM, Megerman J, Hasson JE, L'Italien G, Warnock DF. Effect of compliance mismatch on vascular graft patency. J Vasc Surg 1987; 5: 376-382.